Skip to content

Clinical trials

Lymphoma, B-Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: Belgium Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20102
20111
20132
20141
20163
20171
20182
20192
20201
20215
20226
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting10
Recruiting3
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Pfizer3
The Lymphoma Academic Research Organisation3
Hoffmann-La Roche2
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
Acerta Pharma BV1
Amgen1
Celgene1
Debiopharm International SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell32
Lymphoma, Non-Hodgkin13
Lymphoma8
Lymphoma, Large B-Cell, Diffuse6
Hematologic Diseases4
Leukemia, Lymphocytic, Chronic, B-Cell4
Neoplasms4
Recurrence4
Burkitt Lymphoma3
Leukemia2

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.